CancerSpot: A multi-cancer early detection test developed and validated on a retrospective cohort

Abstract

Next-generation sequencing (NGS) technologies have transformed biomarker discovery, enabling the detection of disease-associated markers at the earliest stages of illness. In this study, we introduce a blood-based, non-invasive test for multi-cancer detection using cell-free DNA (cfDNA) methylation sequencing. The test employs a novel methylation scoring system derived from sequencing data and integrates machine learning to analyze a retrospective cohort of newly diagnosed cancer cases and controls recruited from multiple centers across India. To enhance robustness, the study includes a substantial proportion of controls with habitual tobacco and alcohol use, ensuring the test's resilience against confounding factors. The test's accuracy was further validated through synthetic data augmentation, demonstrating reliability under conditions of random signal perturbation. At an approximate specificity of 97%, the assay achieves sensitivities of 79.3% for Stage I, 78.4% for Stage II, 78.4% for Stage III, and 86.8% for Stage IV cancers in an independent validation cohort. Additionally, the test demonstrates Top 2 Tissue of Origin (TOO) accuracies of 78.3% for Stage I, 79.3% for Stage II, 82.8% for Stage III, and 69.7% for Stage IV cancers. This blood-based test holds considerable promise for early cancer detection, offering a precise test for cancer screening.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of Hanji Cancer Hospital, Belagavi gave ethical approval for this work Ethics committee/IRB of HCG-Bharath Hospital and Institute of Oncology, Mysore gave ethical approval for this work Ethics committee/IRB of BGS Global hospitals, Bangalore gave ethical approval for this work Ethics committee/IRB of Prakriya Hospital, Bangalore gave ethical approval for this work Ethics committee/IRB of Hridaya Cancer Hospital, Kolhapur gave ethical approval for this work Ethics committee/IRB of Oncopath Lab, Kolhapur gave ethical approval for this work Ethics committee/IRB of Clinicles Shanmuga Hospital, Salem gave ethical approval for this work Ethics committee/IRB of Clinicles Saravana Hospital, Madurai gave ethical approval for this work Ethics committee/IRB of Clinicles Harshamitra Oncology Pvt. Ltd, Trichy gave ethical approval for this work Ethics committee/IRB of Vijayanagara Institute of Medical Sciences, Bellary gave ethical approval for this work Ethics committee/IRB of Clinicles DBR & SK Hospital, Tirupati gave ethical approval for this work Ethics committee/IRB of Erode Cancer Centre, Tamil Nadu gave ethical approval for this work Ethics committee/IRB of Care Hospitals, Hyderabad gave ethical approval for this work Ethics committee/IRB of Onco-Vision, Kolhapur gave ethical approval for this work Ethics committee/IRB of Karnataka Institute of Medical Science, Hubli gave ethical approval for this work Ethics committee/IRB of Clinicles Mahatma Gandhi Cancer Hospital, Miraj gave ethical approval for this work Ethics committee/IRB of Clinicles Kolhapur Cancer Centre, Kolhapur gave ethical approval for this work Ethics committee/IRB of Thangam Hospital, Namakkal gave ethical approval for this work Ethics committee/IRB of Asirvatham Hospital, Madurai gave ethical approval for this work Ethics committee/IRB of Mahatma Gandhi Cancer Hospital, Visakhapatnam gave ethical approval for this work Ethics committee/IRB of Geetanjali Cancer Hospital, Udaipur gave ethical approval for this work Ethics committee/IRB of MRCC Govt Cancer Hospital, Aurangabad gave ethical approval for this work Ethics committee/IRB of Nangal Hospital, Bikaner gave ethical approval for this work Ethics committee/IRB of Dr. Samit Ghosh Clinic, Kolkata gave ethical approval for this work Ethics committee/IRB of Care Multispeciality Hospital,Pune gave ethical approval for this work Ethics committee/IRB of HCG Manavata Cancer Hospital, Nashik gave ethical approval for this work Ethics committee/IRB of Sujan Cancer Hospital, Amravati gave ethical approval for this work Ethics committee/IRB of Galaxy care Multispeciality Hospital, Pune gave ethical approval for this work Ethics committee/IRB of Maxcare Cancer Hospital, Aurangabad gave ethical approval for this work Ethics committee/IRB of RxDx HealthCare, Bangalore gave ethical approval for this work Ethics committee/IRB of HCG, Bangalore gave ethical approval for this work Ethics committee/IRB of Vardan Hospital, Vadodara gave ethical approval for this work Ethics committee/IRB of Unity Hospital, Ahmedabad gave ethical approval for this work Ethics committee/IRB of Siddhi ICU, Vadodara gave ethical approval for this work Ethics committee/IRB of Valentis Hospital, Meerut gave ethical approval for this work Ethics committee/IRB of Krishna Institute of Medical Sciences, Karad gave ethical approval for this work Ethics committee/IRB of Shri Siddhivinayak Cancer Hospital, Miraj gave ethical approval for this work Ethics committee/IRB of Pacific Hospital, Udaipur gave ethical approval for this work Ethics committee/IRB of CNCI Hospital, Kolkata gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript and it's supplementary figures/tables.

留言 (0)

沒有登入
gif